|
2024-08-09 |
2024-08-08 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
260,873
-4.0%
0.19
USD 50,009
|
260,873
-4.0%
|
0.19
|
USD 50,009
|
|
|
2024-08-09 |
2024-08-07 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
61,488
-0.9%
0.18
USD 11,197
|
61,488
-0.9%
|
0.18
|
USD 11,197
|
|
|
2024-08-07 |
2024-08-06 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
55,732
-0.8%
0.18
USD 10,188
|
55,732
-0.8%
|
0.18
|
USD 10,188
|
|
|
2024-08-07 |
2024-08-05 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
164,523
-2.4%
0.19
USD 30,996
|
164,523
-2.4%
|
0.19
|
USD 30,996
|
|
|
2024-08-05 |
2024-08-02 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
286,200
-4.0%
0.20
USD 57,354
|
286,200
-4.0%
|
0.20
|
USD 57,354
|
|
|
2024-08-05 |
2024-08-01 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
63,564
-0.9%
0.22
USD 13,743
|
63,564
-0.9%
|
0.22
|
USD 13,743
|
|
|
2024-07-30 |
2024-07-30 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
756,835
-9.5%
0.22
USD 167,185
|
756,835
-9.5%
|
0.22
|
USD 167,185
|
|
|
2024-07-30 |
2024-07-29 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
363,949
-4.4%
0.24
USD 85,637
|
363,949
-4.4%
|
0.24
|
USD 85,637
|
|
|
2024-07-30 |
2024-07-26 |
S
Sale
|
Invus Public Equities, L.P.
Large shareholder
|
258,335
-3.0%
0.24
USD 62,440
|
258,335
-3.0%
|
0.24
|
USD 62,440
|
|
|
2024-06-24 |
2024-06-21 |
B
Purchase
|
Rock Edwin
Chief Medical Officer
Officer
|
115,000
+20.3%
0.27
USD 30,717
|
115,000
+20.3%
|
0.27
|
USD 30,717
|
|
|
2024-06-24 |
2024-06-20 |
B
Purchase
|
Rock Edwin
Chief Medical Officer
Officer
|
190,000
+50.6%
0.25
USD 48,108
|
190,000
+50.6%
|
0.25
|
USD 48,108
|
|
|
2024-06-20 |
2024-06-18 |
B
Purchase
|
Hahn Brian M.
SVP Finance, CFO
Officer
|
17,500
+32.9%
0.25
USD 4,335
|
17,500
+32.9%
|
0.25
|
USD 4,335
|
|
|
2023-09-25 |
2023-09-22 |
B
Purchase
|
Rock Edwin
Chief Medical Officer
Officer
|
30,403
+8.8%
1.38
USD 41,956
|
30,403
+8.8%
|
1.38
|
USD 41,956
|
|
|
2023-09-25 |
2023-09-21 |
B
Purchase
|
Rock Edwin
Chief Medical Officer
Officer
|
35,000
+11.3%
1.38
USD 48,300
|
35,000
+11.3%
|
1.38
|
USD 48,300
|
|
|
2023-05-18 |
2023-05-17 |
S
Sale
|
Hahn Brian M.
SVP Finance, CFO
Officer
|
3,700
-6.5%
1.95
USD 7,215
|
3,700
-6.5%
|
1.95
|
USD 7,215
|
|
|
2023-05-11 |
2023-05-10 |
B
Purchase
|
JUNIUS DANIEL M
Non-Executive Director
|
30,000
+47.4%
1.56
USD 46,800
|
30,000
+47.4%
|
1.56
|
USD 46,800
|
|
|
2023-05-09 |
2023-05-08 |
B
Purchase
|
Johnson Bruce S
SVP & Chief Commercial Officer
Officer
|
13,500
+10.8%
1.57
USD 21,195
|
13,500
+10.8%
|
1.57
|
USD 21,195
|
|
|
2023-02-28 |
2023-02-24 |
B
Purchase
|
Invus Public Equities, L.P.
Large shareholder
|
100,000
+1.2%
1.70
USD 170,000
|
100,000
+1.2%
|
1.70
|
USD 170,000
|
|
|
2023-02-23 |
2023-02-23 |
B
Purchase
|
Invus Public Equities, L.P.
Large shareholder
|
200,000
+2.4%
1.75
USD 350,760
|
200,000
+2.4%
|
1.75
|
USD 350,760
|
|
|
2023-02-23 |
2023-02-22 |
B
Purchase
|
Invus Public Equities, L.P.
Large shareholder
|
150,000
+1.8%
1.79
USD 268,995
|
150,000
+1.8%
|
1.79
|
USD 268,995
|
|
|
2023-02-23 |
2023-02-21 |
B
Purchase
|
Invus Public Equities, L.P.
Large shareholder
|
50,000
+0.6%
1.85
USD 92,500
|
50,000
+0.6%
|
1.85
|
USD 92,500
|
|
|
2023-02-17 |
2023-02-17 |
B
Purchase
|
Invus Public Equities, L.P.
Large shareholder
|
200,000
+2.5%
1.71
USD 341,000
|
200,000
+2.5%
|
1.71
|
USD 341,000
|
|
|
2023-02-17 |
2023-02-16 |
B
Purchase
|
Invus Public Equities, L.P.
Large shareholder
|
315,266
+4.2%
1.68
USD 531,129
|
315,266
+4.2%
|
1.68
|
USD 531,129
|
|
|
2023-02-17 |
2023-02-15 |
B
Purchase
|
Invus Public Equities, L.P.
Large shareholder
|
1,000,000
+15.2%
2.16
USD 2,155,800
|
1,000,000
+15.2%
|
2.16
|
USD 2,155,800
|
|
|
2023-02-13 |
2023-02-09 |
B
Purchase
|
Invus Public Equities, L.P.
Large shareholder
|
11,451
+0.2%
3.24
USD 37,123
|
11,451
+0.2%
|
3.24
|
USD 37,123
|
|
|
2023-01-27 |
2023-01-26 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
1,351,092
-37.7%
3.12
USD 4,213,786
|
1,351,092
-37.7%
|
3.12
|
USD 4,213,786
|
|
|
2023-01-27 |
2023-01-26 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
1,648,908
-37.7%
3.12
USD 5,142,614
|
1,648,908
-37.7%
|
3.12
|
USD 5,142,614
|
|
|
2023-01-27 |
2023-01-25 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
293,645
-7.6%
3.26
USD 958,428
|
293,645
-7.6%
|
3.26
|
USD 958,428
|
|
|
2023-01-27 |
2023-01-25 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
358,371
-7.6%
3.26
USD 1,169,687
|
358,371
-7.6%
|
3.26
|
USD 1,169,687
|
|
|
2023-01-06 |
2023-01-05 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
32,139
-0.8%
2.76
USD 88,659
|
32,139
-0.8%
|
2.76
|
USD 88,659
|
|
|
2023-01-06 |
2023-01-05 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
39,223
-0.8%
2.76
USD 108,201
|
39,223
-0.8%
|
2.76
|
USD 108,201
|
|
|
2023-01-04 |
2023-01-04 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
45,930
-1.2%
2.91
USD 133,643
|
45,930
-1.2%
|
2.91
|
USD 133,643
|
|
|
2023-01-04 |
2023-01-04 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
56,054
-1.2%
2.91
USD 163,100
|
56,054
-1.2%
|
2.91
|
USD 163,100
|
|
|
2023-01-04 |
2023-01-03 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
78,730
-1.9%
2.99
USD 235,411
|
78,730
-1.9%
|
2.99
|
USD 235,411
|
|
|
2023-01-04 |
2023-01-03 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
96,084
-1.9%
2.99
USD 287,301
|
96,084
-1.9%
|
2.99
|
USD 287,301
|
|
|
2023-01-04 |
2022-12-30 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
54,645
-1.3%
3.02
USD 165,028
|
54,645
-1.3%
|
3.02
|
USD 165,028
|
|
|
2023-01-04 |
2022-12-30 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
66,690
-1.3%
3.02
USD 201,404
|
66,690
-1.3%
|
3.02
|
USD 201,404
|
|
|
2022-12-27 |
2022-12-22 |
B
Purchase
|
Rock Edwin
Chief Medical Officer
Officer
|
110,000
+55.0%
2.25
USD 247,500
|
110,000
+55.0%
|
2.25
|
USD 247,500
|
|
|
2022-11-18 |
2022-11-17 |
B
Purchase
|
JUNIUS DANIEL M
Non-Executive Director
|
20,000
+46.2%
1.87
USD 37,400
|
20,000
+46.2%
|
1.87
|
USD 37,400
|
|
|
2022-11-16 |
2022-11-15 |
B
Purchase
|
Rock Edwin
Chief Medical Officer
Officer
|
100,000
+100.0%
1.66
USD 166,000
|
100,000
+100.0%
|
1.66
|
USD 166,000
|
|
|
2022-11-16 |
2022-11-14 |
B
Purchase
|
Rock Edwin
Chief Medical Officer
Officer
|
100,000
+inf%
1.43
USD 143,000
|
100,000
+inf%
|
1.43
|
USD 143,000
|
|
|
2022-11-14 |
2022-11-11 |
B
Purchase
|
PEARSON TIMOTHY R
Non-Executive Director
|
19,400
+369.5%
1.29
USD 25,026
|
19,400
+369.5%
|
1.29
|
USD 25,026
|
|
|
2022-11-14 |
2022-11-11 |
B
Purchase
|
Semerjian Harout
Chief Executive Officer
Executive Director
|
25,000
+inf%
1.29
USD 32,250
|
25,000
+inf%
|
1.29
|
USD 32,250
|
|
|
2022-11-14 |
2022-11-11 |
B
Purchase
|
Hahn Brian M.
SVP Finance, CFO
Officer
|
20,000
+54.3%
1.06
USD 21,200
|
20,000
+54.3%
|
1.06
|
USD 21,200
|
|
|
2022-11-14 |
2022-11-11 |
B
Purchase
|
Girard Armand
SVP, Chief Business Officer
Officer
|
6,500
+28.7%
1.05
USD 6,825
|
6,500
+28.7%
|
1.05
|
USD 6,825
|
|
|
2022-11-14 |
2022-11-11 |
B
Purchase
|
Magnani John L.
SVP of Research, CSO
Officer
|
45,045
+14.0%
1.17
USD 52,703
|
45,045
+14.0%
|
1.17
|
USD 52,703
|
|
|
2022-03-10 |
2022-03-09 |
S
Sale
|
Hahn Brian M.
SVP Finance, CFO
Officer
|
2,917
-7.3%
1.09
USD 3,180
|
2,917
-7.3%
|
1.09
|
USD 3,180
|
|
|
2022-03-10 |
2022-03-09 |
S
Sale
|
Magnani John L.
SVP of Research, CSO
Officer
|
3,227
-1.0%
1.09
USD 3,517
|
3,227
-1.0%
|
1.09
|
USD 3,517
|
|
|
2022-03-10 |
2022-03-09 |
S
Sale
|
Girard Armand
SVP, Chief Business Officer
Officer
|
2,339
-9.4%
1.09
USD 2,550
|
2,339
-9.4%
|
1.09
|
USD 2,550
|
|
|
2021-11-18 |
2021-11-16 |
B
Purchase
|
Andrews Patricia S
Non-Executive Director
|
40,000
+761.9%
2.05
USD 82,000
|
40,000
+761.9%
|
2.05
|
USD 82,000
|
|
|
2020-12-30 |
2020-12-28 |
PS
Planned sale
|
King Rachel K.
President, CEO
Executive Director
|
84,176
-19.1%
3.91
USD 329,128
|
84,176
-19.1%
|
3.91
|
USD 329,128
|
|
|
2020-11-06 |
2020-11-04 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
86,090
+15.8%
2.60
USD 223,834
|
86,090
+15.8%
|
2.60
|
USD 223,834
|
|
|
2020-11-06 |
2020-11-04 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
506,155
+15.8%
2.60
USD 1,316,003
|
506,155
+15.8%
|
2.60
|
USD 1,316,003
|
|
|
2020-11-06 |
2020-11-04 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
674,492
+15.7%
2.60
USD 1,753,679
|
674,492
+15.7%
|
2.60
|
USD 1,753,679
|
|
|
2020-11-03 |
2020-10-30 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
15,472
+2.9%
2.75
USD 42,548
|
15,472
+2.9%
|
2.75
|
USD 42,548
|
|
|
2020-11-03 |
2020-10-30 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
250,755
+8.5%
2.75
USD 689,576
|
250,755
+8.5%
|
2.75
|
USD 689,576
|
|
|
2020-11-03 |
2020-10-30 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
666,385
+18.3%
2.75
USD 1,832,559
|
666,385
+18.3%
|
2.75
|
USD 1,832,559
|
|
|
2020-03-10 |
2020-03-09 |
B
Purchase
|
JUNIUS DANIEL M
Non-Executive Director
|
20,000
+111.1%
3.40
USD 68,000
|
20,000
+111.1%
|
3.40
|
USD 68,000
|
|
|
2019-09-09 |
2019-09-05 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
124,956
+30.9%
3.18
USD 397,610
|
124,956
+30.9%
|
3.18
|
USD 397,610
|
|
|
2019-09-09 |
2019-09-05 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
689,834
+30.4%
3.18
USD 2,195,052
|
689,834
+30.4%
|
3.18
|
USD 2,195,052
|
|
|
2019-09-09 |
2019-09-05 |
B
Purchase
|
BVF PARTNERS L P/IL
Large shareholder
|
853,956
+30.7%
3.18
USD 2,717,288
|
853,956
+30.7%
|
3.18
|
USD 2,717,288
|
|
|
2019-08-15 |
2019-08-13 |
B
Purchase
|
JUNIUS DANIEL M
Non-Executive Director
|
10,000
+125.0%
3.18
USD 31,800
|
10,000
+125.0%
|
3.18
|
USD 31,800
|
|
|
2018-10-18 |
2018-10-18 |
S
Sale
|
Magnani John L.
SVP of Research, CSO
Executive Director
|
3,527
-4.4%
14.02
USD 49,449
|
3,527
-4.4%
|
14.02
|
USD 49,449
|
|
|
2018-10-18 |
2018-10-17 |
S
Sale
|
Magnani John L.
SVP of Research, CSO
Executive Director
|
7,273
-8.4%
14.00
USD 101,822
|
7,273
-8.4%
|
14.00
|
USD 101,822
|
|
|
2018-10-18 |
2018-10-16 |
S
Sale
|
Magnani John L.
SVP of Research, CSO
Executive Director
|
14,200
-14.1%
14.01
USD 198,942
|
14,200
-14.1%
|
14.01
|
USD 198,942
|
|
|
2018-06-12 |
2018-06-11 |
S
Sale
|
Hahn Brian M.
CFO
|
19,345
-100.0%
18.04
USD 348,984
|
19,345
-100.0%
|
18.04
|
USD 348,984
|
|
|
2018-05-11 |
2018-05-10 |
S
Sale
|
BARRIS PETER J
Large shareholder
|
5,533
-0.1%
17.81
USD 98,543
|
5,533
-0.1%
|
17.81
|
USD 98,543
|
|
|
2018-05-11 |
2018-05-10 |
S
Sale
|
BARRIS PETER J
Large shareholder
|
4,006
-0.1%
17.81
USD 71,347
|
4,006
-0.1%
|
17.81
|
USD 71,347
|
|
|
2018-05-11 |
2018-05-10 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
5,533
-0.1%
17.81
USD 98,543
|
5,533
-0.1%
|
17.81
|
USD 98,543
|
|
|
2018-05-11 |
2018-05-10 |
S
Sale
|
SANDELL SCOTT D
Large shareholder
|
4,006
-0.1%
17.81
USD 71,347
|
4,006
-0.1%
|
17.81
|
USD 71,347
|
|
|
2018-05-11 |
2018-05-10 |
S
Sale
|
BARRETT M JAMES
Non-Executive Director
Large shareholder
|
5,533
-0.1%
17.81
USD 98,543
|
5,533
-0.1%
|
17.81
|
USD 98,543
|
|
|
2018-05-11 |
2018-05-10 |
S
Sale
|
BARRETT M JAMES
Non-Executive Director
Large shareholder
|
4,006
-0.1%
17.81
USD 71,347
|
4,006
-0.1%
|
17.81
|
USD 71,347
|
|
|
2018-05-11 |
2018-05-10 |
S
Sale
|
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
|
5,533
-0.1%
17.81
USD 98,543
|
5,533
-0.1%
|
17.81
|
USD 98,543
|
|
|
2018-05-11 |
2018-05-10 |
S
Sale
|
NEW ENTERPRISE ASSOCIATES 10 L P
Large shareholder
|
4,006
-0.1%
17.81
USD 71,347
|
4,006
-0.1%
|
17.81
|
USD 71,347
|
|
|
2017-12-12 |
2017-12-08 |
S
Sale
|
Thackray Helen M.
SVP Clinical Development, CMO
|
2,000
-1.3%
15.01
USD 30,020
|
2,000
-1.3%
|
15.01
|
USD 30,020
|
|
